The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...

Thermo Fisher Scientific is acquiring Clario for roughly $8.9 billion, a major move to boost its clinical research services.

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Operationally, we received FDA 510 (k) clearance for the OneRF trigeminal nerve ablation system, advanced the development of our spinal cord stimulation electrode for lower back pain, initiated a new ...

Operator: Good day, ladies and gentlemen. Welcome to the Fourth Quarter of Fiscal Year 2025 Financial Results Conference Call for NeuroOne Medical Technologies Corporation. Today’s call will be ...

Collaboration with Science Tokyo spinout underscores GlycoNex's integrated antibody development and manufacturing capabilities in support of first-in-class immunotherapies The initiation of the Phase ...